Page last updated: 2024-12-10

2,5,7,8-tetramethyl-2-(2'-carboxyethyl)-6-hydroxychroman

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,5,7,8-tetramethyl-2-(2'-carboxyethyl)-6-hydroxychroman: structure given in first source; a metabolite of delta-tocopherol [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3082015
MeSH IDM0225380

Synonyms (6)

Synonym
2,5,7,8-tetramethyl-2-(2'-carboxyethyl)-6-hydroxychroman
rac-(5-2h3)-alpha-cehc
2h-1-benzopyran-2-propanoic acid, 3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-
methyl 3-(6-hydroxy-5,7,8-trimethyl-3,4-dihydro-2h-chromen-2-yl)propanoate
DTXSID40863313
methyl 3-(6-hydroxy-5,7,8-trimethyl-3,4-dihydro-2h-1-benzopyran-2-yl)propanoate

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The bioavailability of gamma-tocopherol and metabolites of vitamin E after gamma-tocopherol administration is not well understood."( The effect of gamma-tocopherol administration on alpha-tocopherol levels and metabolism in humans.
Hamamura, K; Hirahara, F; Iwamoto, T; Morinobu, T; Tamai, H; Yoshikawa, S, 2005
)
0.33

Dosage Studied

ExcerptRelevanceReference
" Plasma and urine samples were obtained on days 0, 7, 14, 21, and 28 (7 days after the final supplement) of each dosing period and the strength of the underlying association between responses determined using Kendall's tau_b test."( Inter- and intra-individual vitamin E uptake in healthy subjects is highly repeatable across a wide supplementation dose range.
Kelly, FJ; Lee, R; Mudway, IS, 2004
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (34)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (14.71)18.2507
2000's23 (67.65)29.6817
2010's5 (14.71)24.3611
2020's1 (2.94)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.94 (24.57)
Research Supply Index3.71 (2.92)
Research Growth Index4.65 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials5 (14.29%)5.53%
Reviews1 (2.86%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other29 (82.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]